Down-regulation of MicroRNA-205 promotes gastric cancer cell proliferation

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 7, 2014, Pages 1027-1032

  Yin, W Z ^a   Li, F ^a   Zhang, L ^a   Ren, X P ^a   Zhang, N ^a   Wen, J F ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; MiR 205; Tumorigenesis; Yin Yang 1

Indexed keywords

MICRORNA 205; TRANSCRIPTION FACTOR YY1; MICRORNA; YY1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CELL CYCLE PROGRESSION; CELL PROLIFERATION ASSAY; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; WESTERN BLOTTING; CELL PROLIFERATION; DNA MICROARRAY; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH; STOMACH TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH; STOMACH NEOPLASMS; YY1 TRANSCRIPTION FACTOR;

EID: 84902215621     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. SHAH MA. Gastrointestinal cancer: targeted therapies in gastric cancer-the dawn of a new era. Nat Rev Clin Oncol 2014; 11: 10-11.
2. WADHWA R, SONG S, LEE J.S., YAO Y., WEI Q, AJANI JA Gastric cancer-molecular and clinical dimensions. Nat Rev Clin Oncol 2013; 10: 643-655.
3. SUN K, LAI EC Adult-specific functions of animal micrornas. Nat Rev Genet 2013; 14: 535-548.
4. HERMEKING H. Micrornas in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer 2012; 12: 613-626.
5. RYAN BM, ROBLES AI, HARRIS CC Genetic variation in microrna networks: the implications for cancer research. Nat Rev Cancer 2010; 10: 389-402.
6. HE X.P., SHAO Y, LI X.L., XU W., CHEN GS, SUN HH, XU HC, XU X, TANG D., ZHENG X F, XUE Y P, HUANG GC, SUN WH. Downregulation of mir-101 in gastric cancer correlates with cyclooxygenase-2 overex-pression and tumor growth. FEBS J 2012; 279: 4201-4212.
7. WANG J, CHEN X, LI P., SU L, YU B, CAI Q., LI J, YU Y, LIU B, ZHU Z. Crkl promotes cell proliferation in gastric cancer and is negatively regulated by mir-126. Chem Biol Interact 2013; 206: 230-238.
8. GAO C, ZHANG Z, LIU W., XIAO S, GU W, LU H. Reduced microrna-218 expression is associated with high nuclear factor kappa b activation in gastric cancer. Cancer 2010; 116: 41-49.
9. LI X, ZHANG Y, ZHANG H., LIU X, GONG T, LI M., SUN L, JI G, SHI Y, HAN Z, HAN S, NIE Y, CHEN X, ZHAO Q, DING J, WU K, DAIMING F. Mirna-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor epb41l3. Mol Cancer Res 2011; 9: 824-833.
10. LI F, LIU B, GAO Y., LIU Y, XU Y, TONG W., ZHANG A. Up-regulation of microrna-107 induces proliferation in human gastric cancer cells by targeting the transcription factor foxo1. FEBS Lett 2013.
11. LIU K, LI G, FAN C., DIAO Y, WU B, LI J. Increased expression of microrna-221 in gastric cancer and its clinical significance. J Int Med Res 2012; 40: 467-474.
12. KIM JS, YU SK, LEE M.H., PARK MG, PARK E, KIM SG, LEE S.Y., KIM CS, KIM HJ, CHUN HS, CHUN SW, KIM DK. Microrna-205 directly regulates the tumor suppressor, interleukin-24, in human kb oral cancer cells. Mol Cells 2013; 35: 17-24.
13. WANG N, LI Q, FENG N.H., CHENG G., GUAN ZL, WANG Y, QIN C, YIN C.J., HUA LX. Mir-205 is frequently downregulated in prostate cancer and acts as a tumor suppressor by inhibiting tumor growth. Asian J Androl 2013; 15: 735-741.
14. WANG Z, LIAO H, DENG Z., YANG P, DU N, ZHANNG Y., REN H. Mirna-205 affects infiltration and metastasis of breast cancer. Biochem Biophys Res Commun 2013; 441: 139-143.
15. LEI L, HUANG Y, GONG W. Mir-205 promotes the growth, metastasis and chemoresistance of nsclc cells by targeting pten. Oncol Rep 2013; 30: 2897-2902.
16. ALLA V, KOWTHARAPU BS, ENGELMANN D, EMMRICH S., SCHMITZ U, STEDER M, PUTZER BM E2f1 confers anticancer drug resistance by targeting abc transporter family members and bcl-2 via the p73/dnp73-mir-205 circuitry. Cell Cycle 2012; 11: 3067-3078.
17. LU Y, MA Z, ZHANG Z., XIONG X, WANG X, ZHANG H., SHI G, XIA X, NING G, LI X. Yin yang 1 promotes hepatic steatosis through repression of farnesoid x receptor in obese mice. Gut 2014; 63: 170-178.
18. NICHOLSON S, WHITEHOUSE H, NAIDOO K., BYERS RJ Yin yang 1 in human cancer. Crit Rev Oncog 2011; 16: 245-260.
19. YANG Y, ZHOU L, LU L., WANG L, LI X, JIANG P., CHAN LK, ZHANG T, YU J, KWONG J, CHEUNG TH, CHUNG T, MAK K, SUN H, WANG H. A novel mir-193a-5p-yy1-apc regulatory axis in human endometrioid en-dometrial adenocarcinoma. Oncogene 2013; 32: 3432-3442.
20. ZHANG N, LI X, WU C.W., DONG Y., CAI M, MOK MT, WANG H, CHEN J., NG SS, CHEN M, SUNG JJ, YU J. Microrna-7 is a novel inhibitor of yy1 contributing to colorectal tumorigenesis. Oncogene 2013; 32: 5078-5088.
21. PIOVAN C, PALMIERI D, DI LEVA G, BRACCIOLI L, CASALINI P., NUOVO G, TORTORETO M, SASSO M, PLANTAMURA I, TRIULZI T, TACCIOLI C, TAGLIABUE E, IORIO M V, CROCE CM. Oncosuppressive role of p53-induced mir-205 in triple negative breast cancer. Mol Oncol 2012; 6: 458-472.
22. ZHANG T, ZHANG J, CUI M., LIU F, YOU X, DU Y., GAO Y, ZHANG S, LU Z, YE L, ZHANG X. Hepatitis b virus x protein inhibits tumor suppressor mir-205 through inducing hypermethylation of mir-205 promoter to enhance carcinogenesis. Neoplasia 2013; 15: 1282-1291.